Skip to main content
Back to Accel

Accel's Therapeutics Portfolio

Browse 4 Therapeutics companies funded by Accel. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
4
Total Funding in Therapeutics
$121.5M

Therapeutics Portfolio Companies (4)

Export
BiotechnologyHealth CareMedicalTherapeutics

Syantra is a precision biotechnology company that transforms cancer detection and treatment.

Calgary, Canada
September 2025
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyTherapeutics

Automera focuses on a novel therapeutic methods to develop drugs.

Singapore, Singapore
September 2023
$16.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.

Minneapolis, United States
September 2026
$5.5M
Series A

Founder Contacts

41,000+ verified contacts

Health CareInformation TechnologyInsuranceMental HealthTherapeutics

Headway builds a mental healthcare system that enables therapists to accept insurance and scale their practices.

New York, United States
July 2024
$100.0M
Series D

Founder Contacts

41,000+ verified contacts

Explore Accel's Full Portfolio

View all companies funded by Accel across every industry and funding stage.

View Full Accel Portfolio